Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2003
12/09/2003CA2104776C Thalidomide derivatives, method of manufacture and use thereof in medicaments
12/04/2003WO2003099818A1 Substituted quinazolinone compounds
12/04/2003WO2003099814A1 Calcium receptor modulating agents
12/04/2003WO2003099811A1 Kinase inhibitors
12/04/2003WO2003099810A2 Radiopharmaceuticals for imaging infection and inflammation
12/04/2003WO2003099809A1 HETEROCYCLIC COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY α4 INTEGRINS
12/04/2003WO2003099808A1 Substituted heterocyclic compounds and methods of use
12/04/2003WO2003099807A1 New indolylpiperidine derivatives as potent antihistaminic and antiallergic agents
12/04/2003WO2003099796A1 Protein kinase inhibitors
12/04/2003WO2003099795A1 4-substituted imidazole-2-thiones and imidazol-2-ones as agonists of the alpha-2b and alpha-2c adrenergic receptors
12/04/2003WO2003099793A1 1,2-azole derivatives with hypoglycemic and hypolipidemic activity
12/04/2003WO2003099787A1 Novel piperidine compound
12/04/2003WO2003099786A2 Aromatic sulfones and their medical use
12/04/2003WO2003099776A1 Calcium receptor modulating arylalkylamines
12/04/2003WO2003099771A2 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
12/04/2003WO2003099765A1 β-ALANINE DERIVATIVE AND USE THEREOF
12/04/2003WO2003099284A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
12/04/2003WO2003099276A1 1,1-disubstituted cycloalkyl derivatives as factor xa inhibitors
12/04/2003WO2003099274A1 Hepatitis c virus inhibitors
12/04/2003WO2003099266A2 Acetamides and benzamides that are useful in treating sexual dysfunction
12/04/2003WO2003099221A2 Methods for using jnk inhibitors for treating or preventing disease-related wasting
12/04/2003WO2003099211A2 Mitotic kinesin inhibitors
12/04/2003WO2003075921A3 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
12/04/2003WO2003066604A3 Novel aryl- and heteroarylpiperazines
12/04/2003WO2003063794A3 2,4-pyrimidinediamine compounds and their uses
12/04/2003WO2003059807A3 Crystalline solids of carvedilol and processes for their preparation
12/04/2003WO2003027085A3 3-pyridyl or 4-isoquinolinyl thiazoles as c17,20 lyase inhibitors
12/04/2003WO2002099424A3 Acridone derivatives as labels for fluorescence detection of target materials
12/04/2003WO2002094796A3 Benzo[g]quinoxaline derivatives as effective compounds against infectious diseases
12/04/2003WO2002065977A3 Compounds co-inducing cholinergic up-regulation and inflammation down-regulation and uses thereof
12/04/2003US20030225288 Small organic compounds to modulate chemokine receptor activity; treating psoriasis, autoimmune diseases, multiple sclerosis, graft rejection, infectious diseases; anti-allergen, -arthritic, -inflammatory, carcinogenic agents
12/04/2003US20030225286 2-((3-Cyclohexyl-2-(2,5-dioxo-4-(thiophen-2-yl)methylimida-zol idin-1-yl)propanoyl)amino) thiazole-4-carboxylic acid methyl ester, e.g.; antidiabetic agents; hypoglycemic agents; a glucose sensor in beta-cells and hepatocytes
12/04/2003US20030225285 Oxidizing a protected aminoalcohol to a chiral protected aminoaldehyde and diastereoselectively forming the aminoepoxide from said aminoaldehyde with an organometallic methylene-adding reagent in an appropriate solvent
12/04/2003US20030225271 Compounds useful as reversible inhibitors of cysteine proteases
12/04/2003US20030225270 E.g., 4-acetylamino-N-(1-((4-cyano-1-methylpiperidin-4-yl-carbamoyl)-2 -(cyclohexylethyl)benzamide; Alzheimer's, auto-immune and Crohn's diseases; atherosclerosis; antiarthritic agents; osteoporosis; atherosclerosis
12/04/2003US20030225269 Inhibitors of interleukin-1beta converting enzyme
12/04/2003US20030225228 A catalyst for the polymerization of olefins, contains a titanium zirconium or hafnium complex of a dianionic bidentate ligand, (at least one of donor atoms of the ligand is a nitrogen atom substituted by a pyrrolyl group)
12/04/2003US20030225152 Such as 3-phenylaminomethylene-1,3-dihydroindol-2-one; use treating cancer, blood vessel proliferative disorders, fibrotic disorders, mesangial cell proliferative disorders and metabolic diseases
12/04/2003US20030225151 Pyrazole compositions useful as inhibitors of ERK
12/04/2003US20030225150 Method of using a COX-2 inhibitor and a topoisomerase II inhibitor as a combination therapy in the treatment of neoplasia
12/04/2003US20030225148 Biological methods of use of 4-amino-3-mercapto-triazoles
12/04/2003US20030225142 Chain-modified pyridino-N substituted nicotine compounds for use in the treatment of CNS pathologies
12/04/2003US20030225138 3-(2,6-Dichloro-4-pyrydyl)-5-(substituted or nonsubstitutedbenzyl)- 2,4-imidazolidinedione derivatives useful for the treatment of inflammatory diseases
12/04/2003US20030225137 2-pyridinyl)-methyl)sulfinyl)-1H-benzimidazole derivatives
12/04/2003US20030225136 Heterocyclic imines such as (5)6-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-1H -benzimidazole and salts, used as antisecretory agents
12/04/2003US20030225135 Dry-blend pharmaceutical formulations
12/04/2003US20030225128 For treating conditions such as erectile dysfunction, cardiovascular disorders, male or female sexual dysfunction, diabetes mellitus, and gastrointestinal disorders
12/04/2003US20030225121 Treatment of a disorder of the central nervous system related to or affected by the 5-HT6 receptor
12/04/2003US20030225115 Anticoagulants
12/04/2003US20030225111 Use of a quinazoline derivative such as 1-(2,6-dichloro-phenyl)-3-(7-(3-morpholinopropoxy)quinazolin-4-yl) urea to produce an antiangiogenic and/or vascular permeability reducing effect
12/04/2003US20030225108 Process for making substituted pyrazoles
12/04/2003US20030225106 Prophylaxis and treatment of angiogenesis mediated diseases such as cancer
12/04/2003US20030225105 New linear cyclic ureas
12/04/2003US20030225102 Dipeptidyl peptidase inhibitors; heterocyclic amide and semicarbazide derivatives, e.g., (2-Cyano-1-(piperazine-2-yl)-carbonyl pyrrolidine bis-trifluoroacetate
12/04/2003US20030225090 Oxindole derivatives
12/04/2003US20030225089 Pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
12/04/2003US20030225085 For reducing neuronal cell death in response to a traumatic event
12/04/2003US20030225084 Have an affinity for the gabapentin binding site and can be used to treat conditions such as pain, epilepsy, migraine and others.
12/04/2003US20030225082 1,2-dihydropyrazol-3-ones which controls inflammatory cytokines
12/04/2003US20030225081 Pyridazinones and triazinones and medicinal use thereof
12/04/2003US20030225077 Naphthylamines used to chronic inflammatory diseases.
12/04/2003US20030225068 Particularly useful in the treatment of depression.
12/04/2003US20030225061 Protease inhibitors
12/04/2003US20030225060 Acylated piperidine derivatives as melanocortin-4 receptor agonists
12/04/2003US20030225059 Cyclohexyl derivatives and their use as therapeutic agents
12/04/2003US20030225053 N-arylcarboxamides of fused ring systems including naphthalenes, benzothiophenes, benzofurans and indoles
12/04/2003US20030225042 Antipicornaviral compounds and compositions, their uses, and materials for their synthesis
12/04/2003CA2487315A1 1,2-azole derivatives with hypoglycemic and hypolipidemic activity
12/04/2003CA2487073A1 Methods for using jnk inhibitors for treating or preventing disease-related wasting
12/04/2003CA2486966A1 Substituted quinazolinone compounds
12/04/2003CA2486962A1 Compounds
12/04/2003CA2486564A1 Acetamides and benzamides that are useful in treating sexual dysfunction
12/04/2003CA2486376A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
12/04/2003CA2486187A1 Kinase inhibitors
12/04/2003CA2485166A1 Substituted pyrimidinone and pyridinone compounds
12/04/2003CA2484288A1 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
12/04/2003CA2483627A1 Mitotic kinesin inhibitors
12/03/2003EP1367056A1 Drugs that enhance synaptic responses mediated by AMPA receptors
12/03/2003EP1367054A1 Heterocyclic factor Xa inhibitors
12/03/2003EP1367045A1 Intermediate products, methods for their preparation and use thereof
12/03/2003EP1366043A1 2-heteroaryl-3,4-dihydro-2h-pyrrole derivatives and the use thereof as pesticides
12/03/2003EP1366038A1 Cdk-1 inhibitor oxindoles and the application thereof in therapeutics
12/03/2003EP1366027A1 Combi-molecules having signal transduction inhibitory properties and dna damaging properties
12/03/2003EP1365763A1 Farnesyl protein transferase inhibitor combinations with antiestrogen agents
12/03/2003EP1224181B1 Substituted pyrroles as antiproliferative agents for the treatment of cancer
12/03/2003EP1150963B1 Substituted 4-amino-2-aryltetrahydroquinazolines, their preparation, their use and pharmaceutical compositions comprising them
12/03/2003EP1117659B1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
12/03/2003EP0973395B1 Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them
12/03/2003EP0786455B1 Imidazole derivative
12/03/2003CN1460101A Novel compounds inhibiting factor Xa activity
12/03/2003CN1459447A Pyridine derivatives, its preparing process and use as herbicide intermediate
12/03/2003CN1129605C Modified aminoacids, pharmaceuticals containing these compounds and mehtod for their prodn
12/03/2003CN1129604C Amino acid derivatives and their use as thrombin inhibitors
12/03/2003CN1129597C Heterocyclic compounds and antitumor agent containing same as active ingredient
12/03/2003CN1129596C Synthetic intermediate of cephalo olefine compound
12/03/2003CN1129583C Compound as intermediates for use in preparation of optically active 2-imidazoline-5-one or 2-imidazoline-5-thionone derivatives
12/03/2003CN1129579C 1-phenylalkyl-1,2,3,6-tetrahydropyridines for treating alzheimer's disease
12/03/2003CN1129578C Tetrahydrobenzindole derivs
12/03/2003CN1129431C Combination of benzocyclobeptapyridine compounds and antineoplastic drugs for treating proliferative diseases
12/02/2003US6657061 Polymorphic forms of 6-[4-1(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
1 ... 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 ... 1080